PharmaBioSource Realty provided real estate services to Micelle BioPharma on the divestment of its 73,550 SF Riviera Beach, Florida soft gelatin capsule development and manufacturing assets and facility lease to Strides.

• Service: Real Estate
• Sector: Pharmaceuticals
• Sub-sector: Generic Soft Gelatin Capsules
• Engagement Type: Sell Side

PharmaBioSource Realty provided exclusive life sciences real estate services to divest Micelle BioPharma’s FDA licensed soft gelatin capsule development and manufacturing assets and facility in Riviera Beach, Florida. The assets were acquired by Strides along with the facility lease to establish a U.S. manufacturing presence.

PharmaBioSource’s services included a benchmark valuation, buyer target identification, creation of the confidential information memorandum (CIM), data room development and due diligence support.

Press Release